The Center for Viral Hepatitis (CVH) is a non-profit organization with the following missions: 1). to raise awareness on viral hepatitis B and C and their complications in communities local, nationwide and worldwide; 2). to provide linkage to clinical care so that the available healthcare becomes more accessible especially to those disadvantaged; and 3). to conduct clinical studies both locally and globally.
There is a marked disparity between Asian Americans and White Americans in the prevalence of chronic hepatitis B and its complications. For instance, approximately 5-10 % of all Asian Americans have HBV infection compared with 0.1% of White Americans. In the United States, an estimated two million Americans are chronically infected with HBV, with up to 40,000 new infections each year. Nearly 1.4 million out of 2 million chronically infected people are unaware they have the virus. Other studies have also shown that less than 25% of Asian American HBV carriers have been diagnosed, suggesting a large population (undiagnosed) serve as reservoirs for transmission.
Hepatitis C virus (HCV) is a major cause of chronic liver diseases, including cirrhosis and liver cancer. Globally, 130-170 million people(2%–3% of the world’s population) are living with HCV infection, and each year, >350 000 die of cirrhosis and liver cancer. The epidemiology and burden of HCV infection varies throughout the world, with country-specific prevalence ranging from <1% to >10%.